The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Viktor Kocka
Showing 1-4 of 4 articles
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P,
Chang C,
Chevalier B,
West N,
Gori T,
Barbato E,
Tarantini G,
Kocka V,
Achenbach S,
Dudek D,
Escaned J,
Wlodarczak A,
Abdel-Wahab M,
Esposito G,
Tijssen J,
Morice M,
Onuma Y,
van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
Brugaletta S,
Gori T,
Tousek P,
Gomez-Lara J,
Pinar E,
Ortega-Paz L,
Schulz E,
Kocka V,
Münzel T,
Cequier A,
Buono A,
Serruys P,
Sabaté M
March 20, 2020 | 10.4244/EIJ-D-19-00773
Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update
Tousek P,
Kocka V,
Maly M,
Kozel M,
Petr R,
Hajsl M,
Jarkovsky J,
Lisa L,
Buděsinsky T,
Widimský P
May 16, 2016 | 10.4244/EIJV12I1A5
How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?
Martin-Yuste V,
Alvarez-Contreras L,
Sabaté M,
Kelbæk H,
Saunamäki K,
Jørgensen E,
Kocka V
February 20, 2015 | 10.4244/EIJV10I10A208
1
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke